Dr. Mark Rosenblum is a board member of SCP Interventional Radiology, a Shore Capital portfolio company. Dr. Rosenblum is the former Chair Emeritus of the Department of Neurosurgery in the Henry Ford Health System (HFHS), where he developed a department of 32 physicians and scientists that was nationally recognized for research and clinical excellence. There he founded and served as Co-Director of the nationally recognized Hermelin Brain Tumor Center and the HFHS Neuroscience Institute. He also was one of 4 leaders that developed a new patient-focused Henry Ford West Bloomfield Hospital where he served as Vice President of Clinical Programs and Director of its Center for Health Services Transformation. He has served on multiple hospital boards and on the Medtronic Neuroscience Strategic Advisory Board.
Dr. Rosenblum obtained his B.S. at RPI (1965), M.D. at New York Medical College (1969), served as Staff Associate at the NCI (1972) and trained in Neurosurgery at UCSF (1979).